U.S. Other Utilities Stock News

On February 16, 2026, Centerspace released its fourth-quarter results, following earlier expectations for an earnings-per-share improvement and upwardly revised revenue forecasts. The earnings release sharpened focus on the trade-off between improving analyst expectations and ongoing balance sheet pressures, including high leverage and low interest coverage. Now, we'll examine how Centerspace's fourth-quarter earnings expectations amid ongoing leverage concerns may influence the company's...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The nCino, Inc. ( NASDAQ:NCNO ) share price has fared very poorly over the last month, falling by a substantial 33...

Allegion plc's ( NYSE:ALLE ) periodic dividend will be increasing on the 31st of March to $0.55, with investors...

Apollo Global Management, Inc. ( NYSE:APO ) is about to trade ex-dividend in the next 2 days. The ex-dividend date is...

Wondering whether Alvotech at US$4.64 is a potential bargain or a value trap? This article will walk you through what the current price might be implying about the company. The stock has had a tough run, with a 9.7% decline over the last week, 5.7% over the last month and 7.2% year to date, while the 1 year return sits at a 64.3% loss. Recent trading has been shaped by ongoing investor reaction to Alvotech's progress and risks in the biosimilars space, as the market weighs its prospects...

In February 2026, Regal Rexnord reported that fourth-quarter 2025 sales rose to US$1,523.2 million while net income increased to US$63.5 million, with full-year 2025 net income improving to US$279.5 million on slightly lower annual sales of US$5,934.5 million. The company also issued full-year 2026 GAAP diluted EPS guidance of US$5.29 to US$6.09, highlighting management’s confidence after year-over-year earnings growth despite softer annual revenue. With management now guiding 2026 GAAP...

How Walmart (WMT) looks after its recent share performance Recent share price moves have put Walmart (WMT) back on many investors’ screens, with the stock showing positive returns over the past week, month and past 3 months. Here is how the fundamentals compare. See our latest analysis for Walmart. At a share price of US$133.89, Walmart’s recent 30 day share price return of 11.85% and 90 day return of 32.05% point to strong momentum. The 1 year total shareholder return of 29.92%, along with...

If you are wondering whether UiPath is starting to look interesting at current levels, this article will walk through what the recent share price and fundamentals might be telling you about its value. UiPath shares last closed at US$11.32, with returns of 12.9% decline over 7 days, 21.1% decline over 30 days, 28.7% decline year to date, 24.2% decline over 1 year and 27.2% decline over 3 years, which may have shifted how the market is thinking about its risk and potential. Recent headlines...

Abbott Laboratories (ABT) is under fresh legal scrutiny after a wrongful death lawsuit linked alleged defects in its FreeStyle Libre 3 glucose monitors to multiple deaths and serious injuries, drawing investor attention to product safety risk. See our latest analysis for Abbott Laboratories. At a share price of $112.68, Abbott’s recent 1 day and 7 day share price returns of 1.09% and 1.45% sit against a 30 day share price return decline of 7.46% and a 90 day share price return decline of...

Why ADT’s index additions matter for investors ADT (ADT) has just been added to the S&P 600, S&P 1000, S&P Composite 1500, and the S&P 600 Consumer Discretionary index, a shift that can influence trading interest and liquidity. See our latest analysis for ADT. ADT’s recent index additions come after a period where short term share price returns have been soft, with a 7 day share price return decline of 4.56% and a 30 day share price return decline of 6.18%. Meanwhile, the 1 year total...

Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation in the company’s U.S. electrophysiology business. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 15.15% and a 90 day share price return of 24.68%, even though the 3 year total shareholder return sits at 60.57% and the 5 year total shareholder...

Agios Pharmaceuticals reported full-year 2025 results, with revenue rising to US$54.03 million from US$36.5 million, while swinging from net income of US$673.73 million to a very large net loss of US$412.78 million and filing an omnibus mixed-shelf registration covering equity, debt, warrants, and units. Despite the sharp earnings reversal, investors are focusing on stronger-than-expected quarterly performance, growing contributions from PYRUKYND® and newly launched AQVESME™, and the added...

Shopify (NasdaqGS:SHOP) has authorized a $2b share repurchase program, signaling management's focus on returning capital to shareholders. The company is rolling out new AI tools, including Sidekick and its Universal Commerce Protocol, to deepen AI-driven support for merchants. These moves come as Shopify highlights strong growth in its commerce platform and the expanding role of AI in merchant workflows. Shopify, trading at around $112.70, has seen mixed share performance recently, with a 7...

If you are wondering whether Occidental Petroleum's current share price really reflects its underlying value, you are not alone. This article is designed to help you weigh what you are paying against what you are getting. The stock last closed at US$46.07, with recent returns of a 1.3% decline over 7 days, 7.9% over 30 days, 8.7% year to date, a 2.0% decline over 1 year, a 20.3% decline over 3 years, and 84.7% over 5 years. Taken together, this gives you a mixed picture of how the market has...

Earlier this month, HP Inc. amended its bylaws and announced that long-time CEO Enrique Lores stepped down, with board member Bruce Broussard becoming interim CEO while the board conducts a formal search for a permanent successor. At the same time, HP reaffirmed its first-quarter and full-year 2026 earnings guidance and outlined measures to manage higher memory costs and softer demand in PCs and printing, underscoring both continuity and pressure in its operating backdrop. We’ll now examine...

Fastly (FSLY) is back in focus after reporting record fourth quarter results, returning to an adjusted profit and issuing full year 2026 revenue guidance that came in well above earlier analyst expectations. See our latest analysis for Fastly. The latest results have triggered a sharp re-rating in the market, with a 1-day share price return of 13.84% and a 7-day share price return of 109.40%. The 1-year total shareholder return of 126.27% contrasts with a 5-year total shareholder return of...

If you are wondering whether Taiwan Semiconductor Manufacturing's current share price still makes sense for new money, you are not alone. A closer look at what you are paying for is the focus of this article. The stock recently closed at US$366.36, with returns of 3.1% over 7 days, 7.0% over 30 days, 14.6% year to date and 81.6% over 1 year, plus 321.8% over 3 years and 192.9% over 5 years. These moves have come as Taiwan Semiconductor Manufacturing continues to sit at the center of long...

On February 11, 2026, Accenture appointed Rachel Frey as its first chief communications officer, reporting to Chair and CEO Julie Sweet and joining the Global Management Committee. The creation of this new role, building on Frey’s track record positioning Accenture in AI reinvention, signals an increased emphasis on coordinated messaging to employees, investors and broader stakeholders. We’ll now assess how Accenture’s new chief communications officer role, with its AI-focused messaging...

In early February 2026, Carrier Global reported fourth-quarter and full-year 2025 results showing lower revenue and net income, completed a multi-year US$6.77 billion share repurchase program covering 114,888,374 shares, filed a US$3.06 billion shelf registration for 50,074,109 common shares, and highlighted ongoing softness in residential HVAC alongside strength in commercial and data center-related demand. Carrier also introduced a generative AI-based “Tell Me More” feature in its Abound...

In recent days, Tencent Music Entertainment Group has seen its shares react sharply to Chinese government stimulus measures, including interest rate cuts and relaxed mortgage rules that lifted sentiment toward consumer tech platforms. At the same time, investors are weighing concerns about rising competition from Douyin-backed Soda Music and potential margin pressure from Tencent Music’s expansion into concerts and merchandise. Next, we’ll examine how China’s stimulus-driven boost and...

In recent weeks, First Pacific Advisors’ Queens Road Small Cap Value Fund highlighted RLI Corp. as an attractive small-cap specialty insurer, pointing to its stable business, lower valuation multiples, and growing institutional interest. The fund also emphasized RLI’s niche focus and risk-aware culture, where management ties compensation to long-term underwriting profitability and avoids writing unprofitable business. Next, we’ll explore how this endorsement of RLI’s risk culture and...

AMD (NasdaqGS:AMD) and Tata Consultancy Services announced a collaboration to deploy AMD's Helios rack scale AI architecture in India. The partnership targets up to 200MW of AI infrastructure to support India's national AI initiatives. The agreement focuses on co-developing and rolling out AI ready data center solutions for sovereign AI projects. For AMD, which sells CPUs, GPUs and data center accelerators, this move connects its AI hardware directly to a large national build out of...

Oncolytics Biotech (NasdaqCM:ONCY) has moved into focus after the U.S. FDA granted Fast Track Designation to its lead candidate pelareorep in a combination regimen for second line KRAS mutant metastatic colorectal cancer. See our latest analysis for Oncolytics Biotech. The Fast Track announcement has coincided with a sharp near term move, with a 1 day share price return of 26.99% and 7 day share price return of 22.78% taking Oncolytics Biotech to US$1.06. The 1 year total shareholder return...